CG Oncology CGON Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CG Oncology's invested capital?
- CG Oncology (CGON) reported invested capital of $1.07B in Q1 2026.
- How has CG Oncology's invested capital changed year-over-year?
- CG Oncology's invested capital increased by 60.4% year-over-year, from $664.32M to $1.07B.
- What is the long-term trend for CG Oncology's invested capital?
- Over 2 years (2023 to 2025), CG Oncology's invested capital has grown at a 135.7% compound annual growth rate (CAGR), from -$130.91M to $727.13M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).